In this research study, we want to learn more about the V940 (mRNA-4157) vaccine given in combination with pembrolizumab (V940 plus pembro) in people who have surgery to remove their melanoma. This trial will compare V940 plus pembro given after surgery to a placebo plus pembrolizumab given after surgery.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Stergios Moschos
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Melanoma)
23-1126
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
